Clinical-Stage Biotech Ischemix Taps DeWahl as CEO
1/10/2013 7:14:01 AM
More...
|
Ischemix Announces Positive Top Line Data from Phase 2 Clinical Trial of CMX-2043
6/17/2011 7:56:44 AM
More...
|
Ischemix Initiates Phase 2a Trial of CMX-2043 for the Prevention of Ischemia-Reperfusion Injury
3/9/2010 9:44:04 AM
More...
|
Ischemix Appoints Robert DuFresne as Chief Executive Officer
3/24/2009 7:10:28 AM
More...
|